An interventional study of Anchors Away and Parent Enhanced Anchors Away in Anxiety Disorders, Childhood Mental Disorder and Anxiety, sponsored by Kansas City Center for Anxiety Treatment, P.A.. Completed at 1 site in United States. Open to participants aged 6 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-09-02.
Sponsored by Kansas City Center for Anxiety Treatment, P.A. · Not applicable, Interventional, and Prevention
Among 2,266 studies in Anxiety Disorders with a site in United States — 397 open to participants now, 504 under way, 13 of them phase 3. Anxiety Disorders · United States.
Among the 2,266 studies in Anxiety Disorders with a site in United States, this one is the 691st largest by enrollment of the 2,042 interventional ones, is one of 120 that started in 2018, is one of 1,607 with no phase, and was the 822nd registered.
7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
This study's enrollment of 110 is above the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →397 of the 2,266 studies in Anxiety Disorders with a site in United States are open now, in 12 countries. Each count lists the studies.
Of the 943 Anxiety Disorders studies recruiting now, 416 (44%) set no upper age limit and 460 (49%) stop at 75 or younger; 232 take children under 18; 316 take healthy volunteers.
This study: 6 Years to 11 Years · all sexes · healthy volunteers too.
The full table on the hub →2,266 studies; the count open now beside each. This study's row is marked.
First in 1983; this study’s year is marked. 120 started in 2018.
Median enrollment 69 across the 2,042 interventional studies, 156 across the 215 observational. Of the 1,595 that completed or were terminated, 502 (31%) have results posted.
185 of 2,266 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Kansas City Center for Anxiety Treatment, P.A. as lead sponsor.
Kansas City Center for Anxiety Treatment, P.A. has 1 study filed under Anxiety Disorders — fewer than ten, so there is no comparison to draw.
222 of the studies in Anxiety Disorders with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05552053Phase 3Cedars-Sinai Medical CenterResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women | 2026-12-31 |
| NCT05474846Phase 3M.D. Anderson Cancer CenterCombination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer | 2027-02-28 |
| NCT06273527Phase 3University of California, San DiegoEnhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) | 2027-06-01 |
| NCT07123467Phase 3Wayne State UniversityCannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder | 2027-08-31 |
| NCT07718646Oklahoma State UniversityMobile Health Coping Intervention for Mothers Experiencing Food Insecurity | 2026-11 |
Among the 2,266 studies in Anxiety Disorders with a site in United States, from their registry updates:
Anxiety disorders are among the most common psychological disorders, with prevalent onset in childhood and adolescence. While cognitive behavioral therapy (CBT) is considered the first-line treatment for pediatric anxiety, significant barriers remain in accessing CBT and other evidence-based treatments (EBTs), and credible self-help resources based in EBT concepts. This study evaluates a family-guided CBT game application (Anchors App), targeted to children ages 6-11 and their families, which focuses on delivering adaptive CBT-based coping skills to those who have sub-clinical to mild anxiety and related symptoms in a convenient and portable platform. Anchors App will be evaluated in two forms (standard and "parent-enhanced") in comparison to use of a self-help book or waitlist control. The rapid advancements in technology allows richer interactive capacity, content scalability, customizability, and subscription to a broader range of content, which this app capitalizes on in order to increase access to CBT skill concepts directly to pediatric stakeholder populations. If found to be effective, Anchors App has the opportunity to promote engagement of EBT concepts in every-day use through smartphone technology, and will change the landscape of mental health prevention and early intervention for children and families.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Family will receive access to the basic Anchors Away mobile app to test over 6 weeks.
Behavioral: Anchors Away
Family will receive access to the Parent Enhanced Anchors Away mobile app to test over 6 weeks.
Behavioral: Parent Enhanced Anchors Away
Group 3 will receive the Self Help e-Book as a comparative condition (families provided a kindle version copy of "Helping Your Anxious Child: A Step-by-Step Guide" ; Rapee, Wignall, Spence, Lyneham, \& Cobham, 2008).
Behavioral: Self-Help E-Book
Group 4 will not receive any intervention, but will be randomized into an active study arm at 6 weeks.
Modular Cognitive Behavioral Therapy delivered through a mobile app.
Modular Cognitive Behavioral Therapy delivered through a mobile app. Extra modules will focus specifically on parenting skills relevant to having an anxious child.
Parents will read "Helping Your Anxious Child: A Step-by-Step Guide" (Rapee, Wignall, Spence, Lyneham, \& Cobham, 2008)
Spence Children's Anxiety Scale - Parent/Child Report (SCAS)
Parent and child report of anxiety with 6 DSM-IV criteria sub scales. Measuring change in reported anxiety levels in these 6 different domains over time.
Time frame: Entry into study, 6 weeks, 12 weeks
DASS-21
A screener for overall psychological distress of parent with sub scales assessing anxiety, depression, and stress.
Time frame: Entry into study, 6 weeks, 12 weeks
Centre for Epidemiological Studies- Depression Scale for Children (CES-DC)
A 20-item screener for childhood depression and psychological distress
Time frame: Entry into study, 6 weeks, 12 weeks
Anxiety Sensitivity Index- 3 (ASI-3)
A measure of parent anxiety sensitivity (fear of arousal-related sensations) in physical, social, and cognitive domains
Time frame: Entry into study, 6 weeks, 12 weeks
Child Anxiety Sensitivity Index (CASI)
A measure of sensitivity to symptoms of anxiety, similar to the ASI, measuring physical, social, and mental incapacitation concerns in children.
Time frame: Entry into study, 6 weeks, 12 weeks
Behavioral Inhibition Instrument (BII)
A parent-report measure of child behavioral inhibition, which has been determined to be a risk factor for later psychopathology, particularly anxiety.
Time frame: Entry into study, 6 weeks, 12 weeks
Treatment Status and Parent Confidence
Self-report measure to ensure the child is not receiving outside interventions (as would disqualify them from study) and to gauge parents' confidence in managing child's symptoms
Time frame: Entry into study, 3 weeks, 6 weeks, 12 weeks
Opinion on Intervention
Self-report measure to gauge families' thoughts on user-friendliness, perceived effectiveness of intervention, and likelihood to use again or recommend to others
Time frame: 6 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2018 to primary completion in Dec 2019, 16 months.
Of 102 industry-sponsored interventional studies with no phase under Anxiety Disorders, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 16 months is above that.
Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.